Mkts

Sutro Biopharma, Inc.

NASDAQ: STRO
$9.62+0.42 (+4.57%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
9.219.73
52-week range
7.1543.85
Today
Open9.58
Previous close9.62
Volume—
Valuation
Market cap159.51M
P/E ratio—
EPS (TTM)-17.32
Income & risk
Dividend / yield—
Beta1.54
Avg volume311.7K
Discussion

STRO News

Stories mentioning STRO from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue14,52311,6479,69363,74517,39914,8098,52025,706
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development36,55336,64239,85338,32551,59771,03762,10862,020
Sales General & Admin
Total Operating Expenses44,17949,69658,15267,09085,91380,06776,43974,391
Operating Income (Loss)(29,656)(38,049)(48,459)(3,345)(68,514)(65,258)(67,919)(48,685)
Interest Income
Interest Expense
Other Expense
Pretax Income(38,499)(46,844)(56,857)(11,517)(75,961)(70,088)(48,787)(48,010)
Tax Provision(15.00)(82.00)0.00(18.00)7.000.008.00
Net Income (Loss)(38,484)(46,762)(56,857)(11,499)(75,968)(72,443)(48,787)(48,018)
Earnings Per Share (Basic)(2.94)(5.50)(0.67)(0.14)(9.08)(9.36)(0.59)(0.59)
Earnings Per Share (Diluted)(2.94)(5.50)(0.67)(0.14)(9.08)(9.36)(0.59)(0.59)
Weighted Average Shares Outstanding (Basic)13,0828,49884,87084,5808,3647,73782,04481,225
Weighted Average Shares Outstanding (Diluted)13,0828,49884,87084,5808,3647,73782,04481,225

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About STRO

Sutro Biopharma, Inc. (NASDAQ: STRO) is a stock listed on the Nasdaq Stock Market under the ticker symbol STRO. It last traded at $9.62 (Nov 6, 2026, 4:00 PM ET), up 4.6% on the day. That gives Sutro Biopharma a market capitalisation of $159.5M.

Over the past 52 weeks STRO has traded between $7.15 and $43.85.

Revenue for the quarter ended Mar 31, 2026 was $14.5M; a net loss of $38.5M. Revenue was down 16.5% from $17.4M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$14.5M-$38.5M-265.0%
Dec 31, 2025$11.6M-$46.8M-401.5%
Sep 30, 2025$9.7M-$56.9M-586.6%
Jun 30, 2025$63.7M-$11.5M-18.0%

From Sutro Biopharma’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…